Table 5.
Predictive model for mortality of patients with GIB after haplo-HSCT.
| Variables | HR (95% CI) | P value | Multivariate regression coefficient | Points |
|---|---|---|---|---|
| III–IV aGVHD | 2.347 (1.390–3.965) | 0.001 | 0.853 | 1 |
| AKI | 2.957 (1.748–5.001) | 0.000 | 1.084 | 1 |
| Gastrointestinal disease or bleeding before HSCT | 3.438 (1.805–6.550) | 0.000 | 1.235 | 1 |
| TMA | 6.040 (3.075–11.864) | 0.000 | 1.798 | 2 |
| DIC | 4.736 (2.102–10.670) | 0.000 | 1.555 | 2 |
GIB gastrointestinal bleeding, aGVHD acute graft-versus-host disease, TMA thrombotic microangiopathy, DIC disseminated intravascular coagulation, AKI acute kidney injury, HSCT haematopoietic stem cell transplantation.